UK's two week urgent referral standard for suspected bowel cancer hampered by system delaysFebruary 11, 2004The two week maximum wait to see a specialist for UK patients with suspected bowel cancer does not seem to be working well, if the results of one hospital's audit are anything to go by, suggests research in Gut. Although patients referred to the two week clinics were seen more quickly than patients referred elsewhere, they were not treated any more quickly, nor was their disease caught earlier, the audit showed. And family doctors are still not sure about some of the "high risk" criteria for referral. The UK government introduced the standard in July 2000, in a bid to use resources more effectively and push suspected cancer cases to the top of the queue with the aim of catching the disease at an earlier stage.
The authors audited the referrals of all patients with bowel cancer, those given two week referrals, and those referred to other bowel disease clinics at one district general hospital over a period of one year. The hospital in question serves a population of 550,000 patients. During the study period, 249 bowel cancers were diagnosed, only one in four (26%) of which was an urgent two week referral. Of the remainder, 16% were diagnosed during the course of routine outpatient bowel disease clinics; one in four were diagnosed at other clinics; and just over a third (35%) were emergency admissions. Thirteen patients a week were given a two week referral to a specialist, most of whom (85%) were seen within that time. The diagnosis rate was high, with almost one in 10 patients (65 out of 695) diagnosed with bowel cancer, compared with around one in 50 (40 out of 1815) in the routine clinics. This suggests that the referral criteria are not the problem. But most (85%) of the patients referred to the routine clinics actually met the criteria for urgent two week referral. Yet only half of those subsequently diagnosed with bowel cancer had been so referred. Furthermore, referral to a two week clinic had little impact on the length of time patients had to wait for treatment, nor was their disease caught at an earlier stage. This was because the time lags before referral by the family doctor and after the outpatient appointment, which are the major causes of delay in bowel cancer treatment, remained the same. The government should not be deterred from stumping up more money to ensure that all patients with bowel symptoms can be seen promptly, say the authors. But the two week urgent referral is being let down by delays elsewhere in the system. "Ultimately the value of the two week standard is small in the context of a process of care that is slow both before referral and after being seen in outpatients," they comment. British Medical Journal (BMJ) Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Sleeping Sickness Defibrillator Neurogenesis Eating Disorders Greenhouse Gas Tinnitus Blood Vessel Paleontology T Cells Cochlear Implant Fear Superconductors Childhood Obesity Earth-like Planets Behavioral Problems Cancer Patient Ancient Egypt White Blood Cells Palliative Care Cancer Care Food Poisoning Chimpanzees Climate Polycystic kidney disease Arctic sea ice
See More: Science News Tags | |||||||||||||||||||||
|
Related Cancer Current Events and Cancer News Articles Genetically engineered mice yield clues to 'knocking out' cancer Deleting two genes in mice responsible for repairing DNA strands damaged by oxidation leads to several types of tumors, providing additional evidence that such stress contributes to the development of cancer. ADA releases updated position paper on vegetarian diets The American Dietetic Association has released an updated position paper on vegetarian diets that concludes such diets, if well-planned, are healthful and nutritious for adults, infants, children and adolescents and can help prevent and treat chronic diseases including heart disease, cancer, obesity and diabetes. Both good/bad movie characters who smoke influence teens to do the same Dartmouth researchers have determined that movie characters who smoke, regardless of whether they are "good guys" or "bad guys," influence teens to try smoking. Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. Blood stem cell growth factor reverses memory decline in mice A human growth factor that stimulates blood stem cells to proliferate in the bone marrow reverses memory impairment in mice genetically altered to develop Alzheimer's disease, researchers at the University of South Florida and James A. Haley Hospital found. Researchers testing virus-gene therapy combination against melanoma Researchers at the Moores UCSD Cancer Center are injecting a modified herpes virus into melanoma tumors, hoping to kill the cancer cells while also bolstering the body's immune defenses against the disease. Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis. Study shows PET can measure effectiveness of novel breast cancer treatment A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. University of Leicester researchers discover new fluorescent silicon nanoparticles Researchers in the Department of Physics and Astronomy at the University of Leicester have developed a new synthesis method, which has led them to the discovery of fluorescent silicon nanoparticles and may ultimately help track the uptake of drugs by the body's cells. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||